Treatment Action Group

Additional recommended knowledge

Don't let static charges disrupt your weighing accuracy

Daily Sensitivity Test

Daily Visual Balance Check

Treatment Action Group (TAG)

The Treatment Action Group (TAG) is a US-based HIV/AIDS activist organization formed in 1992 involved with worldwide efforts to increase research on treatments for HIV and for deadly co-infections that affect people with HIV, such as hepatitis C and tuberculosis. The group also monitors research on HIV vaccines and fundamental science aimed at understanding the pathogenesis of HIV/AIDS.

History

The Treatment Action Group had its origins in the AIDS activist organization, ACT UP New York. In January 1992, members of the Treatment and Data Committee of ACT UP left the parent group to create a non-profit organization focused on accelerating treatment research. ^[1][2]

During the early 1990s, TAG members advocated with government scientists, drug company researchers, and FDA officials to speed the development of new HIV therapies. The group produced an influential policy report on government investment in basic science, which recommended increasing funding to the National Institutes of Health (NIH) and reorganizing the national AIDS research effort.

Following approval of several effective antiretroviral drugs in 1995, Treatment Action Group pressed government and industry to conduct research to understand the long-term effects of the new drugs. ^[3]

In 2002, TAG began raising awareness of the impact that tuberculosis (TB) was having on people with HIV in the developing world. In 2007, the organization received a $4.7 million grant from the Bill & Melinda Gates Foundation to foster increased international advocacy on TB/HIV research and treatment. ^[4]

Mission Statement

Treatment Action Group’s mission statement describes the group as: “an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS."

TAG works to ensure that all people with HIV receive life saving treatment, care, and information. We are science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. TAG catalyzes open collective action by all affected communities, scientists, and policymakers to end AIDS. ^[5]

References

1. ^ Harrington, Mark. Interview with Sarah Schulman and Jim Hubbard. ACTUP Oral History Project. 16 February 2005. MIX: The New York Lesbian & Gay Experimental Film Festival. 11 December 2005 .
2. ^ TAG at 10: 1992 .
3. ^ TAG at 10 Timeline .
4. ^ TAG TB/HIV Press Release < http://www.aidsinfonyc.org/tag/tbhiv/tagtbhivgrant.html>
5. ^ About TAG .